Zhengye Biotechnology Holding (ZYBT) Non-Current Assets (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Non-Current Assets for 3 consecutive years, with $42.2 million the latest figure, recorded in Q4 2025.

• Quarterly Non-Current Assets fell 4.06% year-over-year to $42.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.2 million (down 4.06% YoY) and the FY2025 annual result came in at $42.8 million, down 1.13% from the prior year.
• Non-Current Assets held at $42.2 million in Q4 2025 per ZYBT's latest filing, from $42.3 million in the prior quarter.
• Over the last five years, Non-Current Assets for ZYBT reached as high as $43.9 million in Q4 2024 and fell as low as $42.2 million in Q4 2025.
• A 3-year average of $42.9 million and a median of $42.7 million in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2024 — Non-Current Assets advanced 1.86% — and 2025, when it retreated 4.06%.
• Year by year, Non-Current Assets stood at $43.1 million in 2023, then gained by 1.86% to $43.9 million in 2024, then declined by 4.06% to $42.2 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $42.2 million, $42.3 million, and $43.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.